Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Non-Current Debt (2023 - 2025)

Cingulate's (CINGW) quarterly Non-Current Debt came in at $1.2 million in Q4 2025, down 52.75% on a YoY basis from $2.4 million in Q4 2024, and up 24.66% quarter-over-quarter from $923698.0 in Q1 2025.

Analysis

Cingulate (CINGW) Non-Current Debt (2023 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Non-Current Debt for 3 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt fell 52.75% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (down 52.75% YoY), and the FY2025 full-year result was $1.2 million, down 52.75% from the prior year.
  • Non-Current Debt advanced to $1.2 million in Q4 2025 per CINGW's latest filing, from $923698.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $2.4 million in Q4 2024 and bottomed at $923698.0 in Q1 2025.
  • Historically, Non-Current Debt has averaged $1.7 million across 3 years, with a median of $2.1 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt climbed 16.04% in 2024, then tumbled 52.75% in 2025.
  • Over 3 years, Non-Current Debt stood at $2.1 million in 2023, then advanced by 16.04% to $2.4 million in 2024, then sank by 52.75% to $1.2 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $1.2 million, $923698.0, and $2.4 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 37.34 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 62.48 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn -
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn -
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn -
10 Cingulate 100,214.03 100,214.03 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.15 Mn
Mar 31, 2025 923,698.00
Dec 31, 2024 2.44 Mn
Dec 31, 2023 2.10 Mn
Sep 30, 2023 2.10 Mn